Stockreport

Shareholders Will Likely Find Sutro Biopharma, Inc.'s (NASDAQ:STRO) CEO Compensation Acceptable [Yahoo! Finance]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF Total compensation is 33% below industry average Sutro Biopharma's three-year loss to shareholders was 77% while its EPS was down 4.2% over the past three years The [Read more]